KORU Medical Systems, Inc. (NASDAQ:KRMD – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the five brokerages that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation and four have issued a buy recommendation on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $7.25.
KRMD has been the subject of a number of analyst reports. B. Riley Financial lifted their price objective on shares of KORU Medical Systems from $7.00 to $8.00 and gave the company a “buy” rating in a research report on Friday, March 13th. Canaccord Genuity Group reissued a “buy” rating and issued a $6.00 price objective on shares of KORU Medical Systems in a research report on Friday, March 13th. Weiss Ratings downgraded shares of KORU Medical Systems from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, May 29th. Finally, Wall Street Zen downgraded shares of KORU Medical Systems from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th.
Get Our Latest Research Report on KRMD
KORU Medical Systems Trading Up 0.3%
KORU Medical Systems (NASDAQ:KRMD – Get Free Report) last issued its quarterly earnings results on Thursday, March 12th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.01. KORU Medical Systems had a negative net margin of 5.27% and a negative return on equity of 13.61%. The firm had revenue of $10.90 million for the quarter, compared to analyst estimates of $10.90 million. As a group, equities research analysts forecast that KORU Medical Systems will post -0.04 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Cubist Systematic Strategies LLC boosted its holdings in shares of KORU Medical Systems by 927.4% during the 1st quarter. Cubist Systematic Strategies LLC now owns 77,280 shares of the company’s stock worth $196,000 after buying an additional 69,758 shares during the period. Goldman Sachs Group Inc. boosted its holdings in shares of KORU Medical Systems by 189.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 242,781 shares of the company’s stock worth $617,000 after buying an additional 158,914 shares during the period. Jane Street Group LLC boosted its holdings in shares of KORU Medical Systems by 136.7% during the 1st quarter. Jane Street Group LLC now owns 163,137 shares of the company’s stock worth $414,000 after buying an additional 94,214 shares during the period. Acadian Asset Management LLC bought a new stake in shares of KORU Medical Systems during the 1st quarter worth about $63,000. Finally, Geode Capital Management LLC boosted its holdings in shares of KORU Medical Systems by 101.3% during the 2nd quarter. Geode Capital Management LLC now owns 997,147 shares of the company’s stock worth $3,571,000 after buying an additional 501,875 shares during the period. Institutional investors own 58.60% of the company’s stock.
About KORU Medical Systems
KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.
Featured Articles
- Five stocks we like better than KORU Medical Systems
- Uranium Energy Corp Melts Down—Nuclear Opportunity at Hand
- Optical Cable Corporation: Strong Earnings, But Hurdles Remain
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
